Pulmonary embolism occurs when thrombus, usually originating in the deep veins of the legs or pelvis, lodges in the pulmonary arteries and obstructs blood flow to the lungs. Risk stratification — from low-risk to massive PE with hemodynamic collapse — drives the intensity of treatment.
Clinical context
This article examines subsegmental pulmonary embolism diagnosis clinical significance and management controversies within the wider field of pulmonary embolism management. A multidisciplinary pulmonary embolism response approach helps match therapy intensity to individual risk. Catheter-directed therapy delivers thrombolysis or mechanical aspiration directly to the pulmonary thrombus, aiming to relieve right-heart strain with a lower systemic drug dose.
Key considerations
- A multidisciplinary pulmonary embolism response approach helps match therapy intensity to individual risk.
- Catheter-directed therapy delivers thrombolysis or mechanical aspiration directly to the pulmonary thrombus, aiming to relieve right-heart strain with a lower systemic drug dose.
- Large-bore aspiration thrombectomy can extract central clot rapidly in appropriately selected patients.
- Right ventricular strain on imaging or biomarkers identifies intermediate-risk patients who may benefit from escalation beyond anticoagulation alone.
Diagnosis and evaluation
Careful patient selection and imaging-based evaluation underpin good outcomes in this area. Terminology that frequently arises includes right ventricular strain, anticoagulation, thrombus, massive PE. A structured assessment helps match the individual patient to the most appropriate treatment pathway.
Treatment approaches and technologies
Large-bore aspiration thrombectomy can extract central clot rapidly in appropriately selected patients. A range of device technologies supports contemporary practice in pulmonary embolism management.
Explore the full Pulmonary Embolism Management portfolio for the devices used across these procedures.
Summary
Subsegmental Pulmonary Embolism Diagnosis Clinical Significance And Management Controversies is an important topic in pulmonary embolism management. Sound patient selection, appropriate technique, and well-matched technology together support safe, effective care. INVAMED develops technologies used by clinicians worldwide across this and related fields.